跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
鄭 雅敏
教授
婦產學科
電子郵件
chengym
mail.ncku.edu
tw
h-index
1607
引文
24
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2024
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(65)
類似的個人檔案
(6)
指紋
查看啟用 Ya-Min Cheng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cervical Cancer
100%
Malignant Neoplasm
57%
Doppler Ultrasound
56%
Doppler Flowmetry
56%
Neoplasm
51%
Adenosquamous Carcinoma
50%
Health Care Cost
50%
Gynecological Oncology
46%
Vascularity
43%
Papanicolaou Stain
43%
Lifespan
43%
Wart Virus
37%
Protein Binding
35%
Quality of Life
35%
Angioleiomyoma
34%
Diseases
32%
Cell Proliferation
31%
Cost-Effectiveness Analysis
28%
Uterine Fibroid
28%
Survival Rate
28%
Ovarian Cancer
27%
Uterine Cancer
27%
Uterine Cervix
27%
Overall Survival
26%
Treatment Response
26%
Hysteroscopy
25%
Sonohysterography
25%
Somatomedin C
25%
Transcription Factor Nrf2
25%
Radical Surgery
25%
Prognostic Factor
25%
Fibrinogen
25%
Broad Ligament
25%
Blastoma
25%
Human Papillomavirus Type 16
25%
RNA Binding Protein
25%
Non Small Cell Lung Cancer
25%
Sebaceous Cyst
25%
Sulforaphane
25%
Cancer Growth Factor
25%
Burkitt's Lymphoma
25%
Insulin-Like Growth Factor 1
25%
Female Genital Tract Tumor
25%
Radiation Therapy
25%
Triage
25%
Biological Functions
25%
Cervical Intraepithelial Neoplasia
25%
Cancer Treatment
25%
Positron Emission Tomography-Computed Tomography
25%
Krukenberg Tumor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
75%
Malignant Neoplasm
65%
Tumor Growth
55%
Sulforaphane
50%
Ovary Carcinoma
50%
Colorectal Carcinoma
50%
Messenger RNA
41%
Carcinogenesis
41%
Diseases
39%
Fibroblast Growth Factor 2
36%
Uterine Cervix Cancer
36%
SCID Mouse
35%
Protein E7
31%
Isothiocyanate
27%
Squamous Cell Carcinoma Antigen
27%
Ovary Cancer
27%
Breast Cancer
27%
Multidrug Resistance
25%
Binding Protein
25%
Fibrinogen
25%
Fibroblast Growth Factor Receptor
25%
Adenosquamous Carcinoma
25%
Cancer Growth Factor
25%
Insulin-Like Growth Factor 1
25%
Drug Resistance
25%
Interstitial Collagenase
25%
RNA Binding Protein
25%
Tumor Antigen
25%
6 Hydroxymelatonin O Sulfate
25%
Pogostemon cablin
25%
Failure Free Survival
25%
Hypophysis Tumor
25%
Human Papillomavirus Type 16
25%
Uterine Cervix Carcinoma
25%
Neuroendocrine Carcinoma
25%
Tissue Inhibitor of Metalloproteinase 3
25%
Cancer Specific Survival
25%
Uterus Myoma
25%
Carcinoma
25%
Peritoneum Adhesion
25%
Peritoneum Cancer
25%
Fas Ligand
21%
Lung Cancer
16%
Antitumor Activity
15%
Progression Free Survival
13%
Chemotherapy
13%
Western Blot
12%
Nude Mouse
12%
Scar Formation
12%
Nanoemulsion
12%
Keyphrases
Cervical Cancer
34%
Taiwan
33%
Lifetime Cost
30%
Early-stage Cervical Cancer
30%
National Health Insurance
26%
PSMD4
25%
Hysteroscopy
25%
Submucous Myoma
25%
Sonohysterography
25%
Pap Test
25%
SCCA2
25%
Macrophage Adhesion
25%
Cesarean Scar Defect
25%
Leiomyoma Uteri
25%
Mitotically Active Leiomyoma
25%
Biological Significance
25%
Indonesia
25%
Sulforaphane
25%
Isothiocyanates
25%
Curcuminoids
25%
Colorectal Cancer Prevention
25%
Radical Surgery
25%
Adenocarcinoma/adenosquamous Carcinoma
25%
Pelvic Lymph Nodes
25%
Transforming Growth Factor-β
25%
Broad Ligament
25%
Angiomyofibroblastoma
25%
Triage
25%
POU4F3
25%
Cancer Treatment
25%
Cost-effectiveness
25%
Lin28
25%
Undergraduate Women
25%
IGF System
25%
TIMP3
25%
Insulin-like Growth Factor Binding Protein (IGFBP)
25%
Health Belief Model
25%
Insulin-like
25%
Intracranial Epidermoid Cyst
25%
Burkitt Lymphoma
25%
Gynecological Tumors
25%
Functional Analysis
25%
Carrier Drug
25%
Anti-PD-L1 mAb
25%
Uterine Leiomyoma Cell
25%
Nationwide Database
25%
Estrogen Deficiency
25%
Fibroids
25%
E7 Oncoprotein
25%
HPV16 E7
25%
